Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?.
Nelson, KN; Churchyard, G; Cobelens, F; Hanekom, WA; Hill, PC; Lopman, B; Mave, V; Rangaka, MX; Vekemans, J; WHITE, RG; Wong, EB; Martinez, L; García-Basteiro, AL;
2023
The Lancet. Microbe, (2023).4 8 10.1016/s2666-5247(23)00112-x.
Modeling the potential health impact of prospective Strep A vaccines.
Giannini, F; Cannon, JW; Cadarette, D; Bloom, DE; Moore, HC; Carapetis, J; ABBAS, K;
2023
NPJ vaccines, (2023).8 1 10.1038/s41541-023-00668-0.
Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study.
Mwenda, V; Jalang'o, R; Miano, C; Bor, J-P; Nyangasi, M; Mecca, L; Were, V; Kariithi, E; Pecenka, C; Schuind, A; ABBAS, K; CLARK, A;
2023
Vaccine, (2023).41 29 10.1016/j.vaccine.2023.05.019.
Covid-19 vaccine roll-out in England: A qualitative evaluation.
MOUNIER-JACK, S; PATERSON, P; BELL, S; Letley, L; Kasstan, B; CHANTLER, T;
2023
PloS one, (2023).18 6 10.1371/journal.pone.0286529.
Considerations for post-licensure group B streptococcus vaccine effectiveness studies.
Skirrow, H; Kajungu, D; Le Doare, K; CHANTLER, T; KAMPMANN, B;
2023
International journal of gynaecology and obstetrics, (2023).162 1 10.1002/ijgo.14845.
Is neglect of self-clearance biassing TB vaccine impact estimates?.
SCARPONI, D; Clark, R; Weerasuriya, C; EMERY, J; Houben, RM G J; WHITE, R; MCCREESH, N;
2023
medRxiv (2023). 10.1101/2023.04.11.23288400.
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study.
OpenSAFELY Collaborative,; PARKER, EP K; Horne, EM F; Hulme, WJ; TAZARE, J; ZHENG, B; Carr, EJ; Loud, F; Lyon, S; MAHALINGASIVAM, V; MacKenna, B; Mehrkar, A; Scanlon, M; Santhakumaran, S; Steenkamp, R; GOLDACRE, B; Sterne, JA C; NITSCH, D; TOMLINSON, LA; LH&W NCS (or CONVALESCENCE) Collaborative,;
2023
The Lancet regional health. Europe, (2023).30, 10.1016/j.lanepe.2023.100636.
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.
Nab, L; PARKER, EP K; Andrews, CD; Hulme, WJ; Fisher, L; Morley, J; Mehrkar, A; MacKenna, B; Inglesby, P; Morton, CE; Bacon, SC J; Hickman, G; Evans, D; Ward, T; Smith, RM; Davy, S; Dillingham, I; Maude, S; Butler-Cole, BF C; O'Dwyer, T; Stables, CL; Bridges, L; Bates, C; Cockburn, J; Parry, J; ... OpenSAFELY Collaborative,
2023
The Lancet Public health, (2023).8 5 10.1016/S2468-2667(23)00079-8.
Adapting SARS-CoV-2 vaccination delivery in England to population needs: a thematic analysis of providers and commissioner's perceptions.
ISMAIL, S; CHANTLER, T; PATERSON, P; Letley, L; BELL, S; MOUNIER-JACK, S;
2023
BMC health services research, (2023).23 1 10.1186/s12913-023-09350-6.
Timing of seasonal influenza epidemics for 25 countries in Africa during 2010-19: a retrospective analysis.
IGBOH, LS; Roguski, K; Marcenac, P; Emukule, GO; Charles, MD; Tempia, S; Herring, B; Vandemaele, K; Moen, A; Olsen, SJ; Wentworth, DE; Kondor, R; Mott, JA; Hirve, S; Bresee, JS; MANGTANI, P; NGUIPDOP-DJOMO, P; Azziz-Baumgartner, E;
2023
The Lancet. Global health, (2023).11 5 10.1016/S2214-109X(23)00109-2.